Harvard Business Review

OCTOBER 26, 2011

In the last year, however, early-stage investments in clean energy production technologies have fallen substantially (see the table at the end of this piece for more detail). Most clean energy startups, on the other hand, need huge amounts of capital to get off the ground, and so far big payoffs have been scarce.

Energy 11

Energy Finance IPO Biotechnology 11

Harvard Business Review

OCTOBER 29, 2012

If the cost of innovation is falling, that should enable more of it from poorer countries, companies or cooperatives. If it's not, the already big and already rich will dominate innovation. Some of this may just be the product of the high regulatory costs in pharmaceuticals, but research by Harvard's F.M.

Cost 8

Cost Innovation Wireless Disruptive Innovation 8

Harvard Business Review

MARCH 28, 2012

The Swiss pharmaceutical giant Roche is nothing if not determined in its quest to acquire Illumina, the San Diego-based leader in genetic-sequencing equipment. An acquirer looking for innovation would have been likelier to try to buy Gateway, a company that is almost an after-thought now. billion tender offer directly to shareholders.

Innovation 13

Innovation Company Biotechnology CFO 13

Harvard Business Review

SEPTEMBER 14, 2011

We recently visited the brand-new R&D lab of Dr Reddy's , one of India's leading pharmaceutical firms. Besides Dr Reddy's, several leading Indian firms are pioneering polycentric innovation: Tata Motors. Polycentric innovation won't work in organizations that promote groupthink. Cambridge, U.K.

Globalization 10

Globalization Innovation Decentralization Chemicals 10

Harvard Business Review

MAY 20, 2014

In pharmaceuticals, the largest company, Pfizer, is the result of decades of mergers. The current corporate entity is comprised of firms that used to be called: King Pharmaceuticals, Wyeth, American Cyanamid, Lederle, Pharmacia, Upjohn, Searle, SUGEN, Warner-Lambert, Parke-Davis and others.

Pharmaceuticals 11

Pharmaceuticals Banking Chemicals Trends 11

Harvard Business Review

JUNE 6, 2011

TNG Pharmaceuticals from University of Louisville developed a vaccine for a parasite that strikes cattle, costing the dairy and beef industry over $1 billion a year. The other winners, FYI, were a better human authentication tool for websites and a material science innovation, a heat-resistant filter made from titanium dioxide.

Pharmaceuticals 15

Pharmaceuticals Entrepreneur Industry Energy 15

Harvard Business Review

JANUARY 24, 2012

Nine years ago, when I launched The Energy Project during an economic boom, it was nearly impossible to find senior leaders open to the idea that demand was exceeding people's capacity, and that it was critical to the bottom line to teach employees new ways to manage their energy more skillfully. The way we're working isn't working.

Meyer 15

Meyer Goleman Emotional Intelligence Pharmaceuticals 15

Harvard Business Review

OCTOBER 23, 2014

Energy, agriculture, insurance, retail, human resources — no industry is unaffected. That’s why pharmaceutical, biotechnology, and medical device companies need to define their relevance in this new health care ecosystem, and soon. Or lenders’ enhanced abilities to gauge credit risk. They’re also sharing risk. But not for long.

Health Care 8

Health Care Pharmaceuticals Information Technology Supply Chain 8

Harvard Business Review

JANUARY 31, 2013

Second, we see a raft of innovations that will alter how products are designed, manufactured and sold — everything from nanotechnologies to 3D printing. Then, manufacturing's most important role is as a driver of innovation, trade, and productivity. Innovations Are Changing The Way We Design Products. but also the risks.

Globalization 9

Globalization Supply Chain Pharmaceuticals McKinsey 9

Harvard Business Review

FEBRUARY 2, 2015

The factory floor at Pittsburgh’s Aquion Energy doesn’t look much like the steel mills that once populated this Rust Belt city. Steel did in an earlier era of manufacturing, Aquion and innovative firms like it are spearheading economic and employment growth across the country. But just as U.S. economy.

Industry 8

Industry McKinsey Engineering Innovation 8

Harvard Business Review

NOVEMBER 27, 2013

Recent events have seen a rash of the departures from large corporates: Steve Ballmer from MicroSoft, Jeremy Levin from Teva Pharmaceutical, and Thorsten Heins from Blackberry. After the initial rush of enthusiasm and energy, established routines and networks can smother the drive for innovation.

CEO 13

CEO Long-term Welch Pharmaceuticals 13

Harvard Business Review

AUGUST 14, 2018

ineffective innovation strategies. 5 Principles for Innovation in Emerging Markets. They operate in an environment where the barriers to entry are relatively low and the focus of competition is on product and business model innovations and service delivery, rather than the most advanced technologies. Related Video.

Competitive Advantage 11

Competitive Advantage Business Model Technology Marketing 11

Harvard Business Review

MAY 8, 2013

I recently conducted a study of 56 randomly selected companies involved in major change and innovation efforts in the high-tech, retail, pharmaceutical, banking, automotive, insurance, energy, non-profit, and health care industries. Nearly 68% of these large-scale change and innovative efforts failed.

Middle Management 9

Middle Management Management Automotive Pharmaceuticals 9

Harvard Business Review

OCTOBER 22, 2013

Innovation starts with new and novel ideas. When we surveyed over 300 global executives between 2008 and 2009, one of the primary concerns they expressed was their inability to compete long term without a solid innovation engine that can grow their top line. Let’s say you’re in the energy sector. Find Pivots.

Skills 8

Skills Power Six Sigma Disruptive Innovation 8

Harvard Business Review

MARCH 1, 2012

Hospira began life when Abbott Laboratories spun off its production division, and it is now the world leader in the production of injectable pharmaceuticals. Second, the bigger CMOs tend to have specialized skills and knowledge that can help their partners innovate. innovation" typically means just one thing to people: novel gadgets.

Contract Manufacturing 9

Contract Manufacturing Offshoring Supply Chain Biotechnology 9

Harvard Business Review

JUNE 16, 2016

The Joint Center For Energy Storage Research (JCESR) has a five-year mandate to develop next generation battery technologies. The Institute for Applied Cancer Science at MD Anderson (IACS) is exploring revolutionary new cures and the National Network for Manufacturing Innovation (NNMI) is working to revive the US production capacity.

Technology 8

Technology Venture Capitalist Supply Chain Innovation 8

Harvard Business Review

APRIL 22, 2013

Most of us think of biotech as the province of multinational pharmaceutical corporations and well-funded ventures, but the founders of BioCurious believe (as they say in their mission statement) "that innovations in biology should be accessible, affordable, and open to everyone." But don''t let that loss of control frighten you.

Mission Statement 9

Mission Statement Class Learning-by-Doing Pharmaceuticals 9

Harvard Business Review

APRIL 16, 2012

energy or telecom) or research-intensive industries (e.g., high technology or pharmaceutical) that are investing in projects with uncertain long-range payoffs. Strategic cash also can be used to finance long-term reinvestment programs in the business—which is especially valuable to companies in capital-intensive industries (e.g.,

Company 14

Company Cost of Capital Finance Long-term 14

Harvard Business Review

DECEMBER 5, 2016

Library leaders knew that given the immense changes brought on by digital innovations, as well as shifts in the communities that the Library served, it would need to evolve. Innovation communities had been used by Best Buy to grow its portion of the women’s consumer electronics market by $4.4b in less than five years.

Library 8

Library Strategy Reference Bottom-up 8

Harvard Business Review

SEPTEMBER 15, 2014

Consider Ashoka , which provides start-up funding and support for social innovators worldwide. As Linda Hill and her colleagues have described, the company needed expert knowledge as it navigated the technically and ethically challenging waters of pharmaceutical development and marketing.

Gilbert 9

Gilbert Participative Cooper Network Economy 9

Harvard Business Review

FEBRUARY 10, 2014

Back in 2006, my colleague Huggy Rao and I launched an executive education program at Stanford called “Customer-focused Innovation.” The most effective campaigns stir up “hot” emotions in people (pride and anger are especially effective) and then channel that energy and passion into “cool” (clear and step-wise) actions.

Case Study 11

Case Study Pharmaceuticals Airlines Hotels 11

Harvard Business Review

MAY 16, 2011

True collaboration always has open-ended elements — ranging from precisely how new innovations will be implemented, to how products will fare in the market, and even to what priorities partners will pursue in the face of changes in the environment. Google uses a different approach to working with multiple external parties.

Software 16

Software Licensing Long-term Telecommunications 16

Harvard Business Review

MARCH 9, 2015

Rather than be paralyzed by fear about who has access to what, savvy leaders recognize that information can empower employees to move the business closer to customers, that decision-making can be accelerated when vital data is not held hostage (or lost) and that visible conversations can prevent wasted effort and even spark innovation.

Tools 8

Tools CEO Mezzanine Software 8

Harvard Business Review

MAY 17, 2013

Sure, the company was eventually both punished and sold (it’s now one of the fastest-growing pharmaceutical businesses in the U.S.). Liars swear more, on average, probably because the cognitive energy required for telling an untruth makes it harder for them to rein in profanities, say Lyn M. In other news, Evgeny Morozov disagrees.).

Pharmaceuticals 8

Pharmaceuticals Course Middle Management Training 8

Harvard Business Review

FEBRUARY 20, 2014

This may all change as China innovates and grows. But we also make super-sophisticated products like jet engines, airplanes, satellites, radar, advanced medical devices, pharmaceuticals, all kinds of chemicals, the world’s most sophisticated robots, military goods, and the world’s most advanced computer chips and computers.

Intellectual Capital 8

Intellectual Capital Magazine Pharmaceuticals Creativity 8

Harvard Business Review

APRIL 13, 2015

But some will require different types of solutions to evolve areas of infrastructure like local government, law enforcement, energy consumption and creation, broadband access, and healthcare. Some of the opportunity will be in the development of on-demand services. Scalable Niches. billion.

Software 8

Software Trends Mass Marketing Marketing 8

Harvard Business Review

SEPTEMBER 20, 2011

A vast ideological gap on macro-economic policy divides Washington and much of the nation, but there is almost universal agreement on one solution: innovation. Innovation is now perceived as a panacea for job creation, income generation, economic growth, dollar strength, and the revival of the U.S. as global hegemon.

Innovation 13

Innovation Supply Chain Offshoring Policies 13

Harvard Business Review

APRIL 19, 2016

has been an innovation superpower. In virtually every advanced field, whether it’s information technology, biotechnology, agriculture, or renewable energy, America holds a leading position. In the pharmaceutical industry, the monitoring process can be incredibly elaborate. vincent tsui FOR HBR. Since World War II, the U.S.

Innovation 8

Innovation Company Competitive Advantage Venture Funding 8

Harvard Business Review

SEPTEMBER 3, 2013

Hilde Dach, the former chief scientist at drug-development start-up Genbac and now a team leader at German pharmaceuticals maker Caliska, which had acquired Genbac, could read disappointment in the face of Johan Greve, the Caliska division head who was her boss. You''ve always seen it as a pharmaceutical product. Hilde turned away.

Case Study 8

Case Study Pharmaceuticals Bottom-up Marketing 8

Strategy Driven

JANUARY 24, 2011

Closing the Execution Gap : How Great Leaders and Their Companies Get Results by Richard Lepsinger If an organization can’t execute its plans and initiatives, nothing else matters: not the most solid, well thought-out strategy, not the most innovative business model, not even technological breakthroughs that could transform an industry.

Execution 67

Execution Company 360-Degree Feedback Cooper 67

Harvard Business Review

NOVEMBER 20, 2015

But entrepreneurial know-how and energy can work very effectively in the context of plugging-in as a supplier, as Steve Cronce and thousands of others are learning. Innovate and invest, even when it hurts. Taking this path isn’t a cake walk, however. Manage culture by setting expectations appropriately.

Supply Chain 8

Supply Chain Collins Golden Handcuff Pharmaceuticals 8

Harvard Business Review

OCTOBER 27, 2014

I studied large-scale change and innovation efforts in 56 randomly selected companies in the high-tech, retail, pharmaceutical, banking, automotive, insurance, energy, non-profit, and health care industries. doubled from 20% to 40% between July and December 2013, and has stayed at that level since.

Middle Management 14

Middle Management Six Sigma Taylorism Taylor 14

Harvard Business Review

MAY 28, 2013

Not innovation, risk management, technology, debt, or the regulatory environment. food, beverage & tobacco, household and personal products); Energy & Utilities (e.g., pharmaceuticals, biotechnology & life sciences, health care equipment and services); Industrials (e.g., And what did they say was their biggest concern?

Talent Management 8

Talent Management Company Telecommunications Management 8

Great Leadership By Dan

FEBRUARY 7, 2014

After motivational ability, the senior executive traits most valued by organizations were: strong ability to manage change (51 percent); ability to identify and develop talent (46 percent); innovative thinking (30 percent); and consistent high performance (26 percent). years), while the pharmaceutical (5.7

Execution 283

Execution Company Press Release Survey 283

Harvard Business Review

NOVEMBER 3, 2017

When everyone in the organization feels empowered to make decisions that can influence change, it creates a palpable energy: People tend to work harder, offer more ideas, and become far more invested in the process. If every activity is the result of a command from on high, the company runs the risk of sucking all the energy out of the room.

Execution 14

Execution Strategy Decentralization Short-term 14

Harvard Business Review

JANUARY 31, 2011

We did not have a lot of competition for developing and producing high-value-added products like semiconductors, airplanes, software, complex electronic systems, high-end computers, telecommunications equipment, and pharmaceuticals. It also potentially means that we will lose our advantage in innovation. fertile ground for innovation.

Real Estate 14

Real Estate Policies Telecommunications Industry 14

Harvard Business Review

JUNE 20, 2017

Firms in innovation-driven industries, such as pharmaceuticals and medical devices, have long supported greater standardization across borders, with stronger intellectual property protections and enforcement of regulatory standards.

Supply Chain 9

Supply Chain Depreciation Uncertainty Marketing 9